PT1035858E - Utilizacao de extracto de ginkgo biloba para preparar um medicamento - Google Patents

Utilizacao de extracto de ginkgo biloba para preparar um medicamento

Info

Publication number
PT1035858E
PT1035858E PT98958285T PT98958285T PT1035858E PT 1035858 E PT1035858 E PT 1035858E PT 98958285 T PT98958285 T PT 98958285T PT 98958285 T PT98958285 T PT 98958285T PT 1035858 E PT1035858 E PT 1035858E
Authority
PT
Portugal
Prior art keywords
ginkgo biloba
prepare
medicinal product
biloba extract
toxicomania
Prior art date
Application number
PT98958285T
Other languages
English (en)
Inventor
Katy Drieu
Original Assignee
Cons De Rec Et D Appli Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cons De Rec Et D Appli Scient filed Critical Cons De Rec Et D Appli Scient
Publication of PT1035858E publication Critical patent/PT1035858E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT98958285T 1997-12-03 1998-12-01 Utilizacao de extracto de ginkgo biloba para preparar um medicamento PT1035858E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9715230A FR2771639B1 (fr) 1997-12-03 1997-12-03 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction

Publications (1)

Publication Number Publication Date
PT1035858E true PT1035858E (pt) 2002-10-31

Family

ID=9514108

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98958285T PT1035858E (pt) 1997-12-03 1998-12-01 Utilizacao de extracto de ginkgo biloba para preparar um medicamento

Country Status (21)

Country Link
US (2) US6936285B1 (pt)
EP (1) EP1035858B1 (pt)
JP (1) JP2001524528A (pt)
KR (1) KR100597139B1 (pt)
CN (1) CN1188141C (pt)
AT (1) ATE216587T1 (pt)
AU (1) AU749752B2 (pt)
CA (1) CA2312856C (pt)
CZ (1) CZ299427B6 (pt)
DE (1) DE69805096T2 (pt)
DK (1) DK1035858T3 (pt)
ES (1) ES2177097T3 (pt)
FR (1) FR2771639B1 (pt)
HU (1) HUP0100223A3 (pt)
IL (1) IL136304A0 (pt)
NO (1) NO323707B1 (pt)
NZ (1) NZ505516A (pt)
PL (1) PL190849B1 (pt)
PT (1) PT1035858E (pt)
RU (1) RU2207140C2 (pt)
WO (1) WO1999027943A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827518B1 (fr) * 2001-07-17 2005-07-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
KR20030080623A (ko) * 2002-04-09 2003-10-17 주식회사 바이오메딕스 금연을 돕는 조성물 및 제조방법
US7169704B2 (en) 2002-06-21 2007-01-30 Samsung Electronics Co., Ltd. Method of cleaning a surface of a water in connection with forming a barrier layer of a semiconductor device
JPWO2005066357A1 (ja) * 2004-01-05 2007-12-20 三菱ウェルファーマ株式会社 精神疾患関連分子のスクリーニング方法
WO2007050599A2 (en) * 2005-10-27 2007-05-03 The Brigham & Women's Hospital, Inc. Ginkgolides in the treatment and prevention of ovarian cancer
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
EP2459205A1 (en) * 2009-07-28 2012-06-06 Velleja Research SRL Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN101946784B (zh) * 2010-09-26 2013-04-03 云南省农业科学院生物技术与种质资源研究所 银杏内酯b在制备抗烟草花叶病毒药物中的应用
CN112089772B (zh) * 2020-09-15 2022-02-18 汉济生物科技（武汉）有限公司 一种药物组合物及其在制备戒毒药物中的应用
CN113144021B (zh) * 2021-05-21 2022-08-19 常州工业职业技术学院 一种戒毒用中药组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE4008046C2 (de) * 1990-03-14 1999-09-16 Irbit Research & Consulting Ag Verfahren zur Herstellung eines Formteils aus Melaminharzschaumstoff
JP2924099B2 (ja) * 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
JP3188461B2 (ja) * 1991-12-23 2001-07-16 ドクター・ビィルマール・シュバーベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・カンパニー 緊張及び不安の処置のためのビロバリドを含有する医薬製剤
JP3181356B2 (ja) * 1992-03-25 2001-07-03 ダイセル化学工業株式会社 中枢神経作用薬
DE4317868C2 (de) * 1993-05-28 1996-04-18 Arrowdean Ltd Neuartiges Anxiolytikum
JPH0753371A (ja) * 1993-08-11 1995-02-28 Daicel Chem Ind Ltd 抗痙攣薬
KR0136986B1 (ko) * 1993-12-31 1998-04-25 김준웅 신규 징코라이드 유도체와 이의 제조방법
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
GB9508533D0 (en) * 1995-04-27 1995-06-14 Sod Conseils Rech Applic Flavonoid extract of ginkgo biloba as flavouring and/or texturing agent

Also Published As

Publication number Publication date
US20040180105A1 (en) 2004-09-16
NO323707B1 (no) 2007-06-25
PL340794A1 (en) 2001-02-26
NO20002775L (no) 2000-06-02
DK1035858T3 (da) 2002-08-19
KR20010032716A (ko) 2001-04-25
CN1280499A (zh) 2001-01-17
FR2771639A1 (fr) 1999-06-04
RU2207140C2 (ru) 2003-06-27
CZ299427B6 (cs) 2008-07-23
JP2001524528A (ja) 2001-12-04
CZ20002007A3 (cs) 2000-11-15
IL136304A0 (en) 2001-05-20
EP1035858A1 (fr) 2000-09-20
NO20002775D0 (no) 2000-05-30
EP1035858B1 (fr) 2002-04-24
HUP0100223A3 (en) 2004-05-28
DE69805096D1 (de) 2002-05-29
HUP0100223A2 (hu) 2001-10-28
FR2771639B1 (fr) 2000-05-05
ES2177097T3 (es) 2002-12-01
AU1438099A (en) 1999-06-16
CA2312856A1 (fr) 1999-06-10
US6936285B1 (en) 2005-08-30
ATE216587T1 (de) 2002-05-15
WO1999027943A1 (fr) 1999-06-10
CN1188141C (zh) 2005-02-09
NZ505516A (en) 2001-10-26
KR100597139B1 (ko) 2006-07-06
DE69805096T2 (de) 2002-11-14
CA2312856C (fr) 2009-04-07
AU749752B2 (en) 2002-07-04
PL190849B1 (pl) 2006-02-28

Similar Documents

Publication Publication Date Title
AR008462A1 (es) COMPOSICIoN FARMACÉUTICA QUE COMPRENDE OLANZAPINA Y CLORHIDRATO DE FLUOXETINA Y USO DE DICHA COMPOSICIoN PARA LA FABRICACIoN DE UN MEDICAMENTO.
ATE232384T1 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
HUP0203623A2 (hu) Tramadol-szacharinátot tartalmazó, késleltetett hatású adagolási forma és alkalmazása
PT1035858E (pt) Utilizacao de extracto de ginkgo biloba para preparar um medicamento
ATE267004T1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
HK1063295A1 (en) Pharmaceutical and/or cosmetic compositions for the treatment of localised adiposities and cellulite
MXPA04002714A (es) Uso de derivados de 2-oxo-1-pirrolidina para el tratamiento de trastornos del movimiento y de la discinesia.
PT1102586E (pt) Utilizacao de extractos de ginkgo biloba para a preparacao de um medicamento para o tratamento da esclerose lateral amiotrofica
MY107420A (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances.
MY120958A (en) Use of a flavonoid extract of ginkgo biloba leaves, and more specifically of a terpene-free extract, in the pharmaceutical and/or cosmetic domain and more particularly in the buccodental domain
ES2177324T3 (es) Preparaciones de insulina destinadas a la entrega pulmonar y que contiene mentol.
BR9706889A (pt) Uso de extratos de ginkgo biloba para a preparação de composições farmacêuticas e processo de tratamento cosmético usando um extrato de ginkgo biloba
DE69823226D1 (de) Pharmazeutische zusammmensetzung, enthaltend ticlopidin und ginkgo biloba extrakt
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
PT825859E (pt) Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool
DK1663267T3 (da) Orale sammensætninger til behandling af cellulite
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
BR0211734A (pt) Derivados do ácido 5,6,6a,11b-tetraidro- 7-oxa-5-aza- benzo [c] fluoreno-6-carboxìlico substituìdos como antagonistas do nmda
HUP9902469A2 (hu) Ginkgo biloba extraktumok alkalmazása gyógyászati kompozíciók előállításához és kozmetikai kezelési eljárás Ginkgo biloba extraktum felhasználásával
ES2178960A1 (es) Utilizacion de fracciones de lanolina ricas en ceramidas para el tratamiento de la piel, y composiciones que las contienen.
GEP19991857B (en) Medicinal Means
UA43011A (uk) Лікувальний засіб "агмелгін"
WO2004052337A3 (de) Nasale pharmazeutische präparation enthaltend eine lipophile flüssige oder gasförmige wirksubstanz